CN111909209A - Preparation method of biphenyl tetradentate phosphonite ligand - Google Patents

Preparation method of biphenyl tetradentate phosphonite ligand Download PDF

Info

Publication number
CN111909209A
CN111909209A CN202010794422.6A CN202010794422A CN111909209A CN 111909209 A CN111909209 A CN 111909209A CN 202010794422 A CN202010794422 A CN 202010794422A CN 111909209 A CN111909209 A CN 111909209A
Authority
CN
China
Prior art keywords
acid
biphenyl
tetradentate
butene
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010794422.6A
Other languages
Chinese (zh)
Inventor
张润通
彭江华
王建新
闫鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huizhou Kailisi Technology Co ltd
Original Assignee
Huizhou Kailisi Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huizhou Kailisi Technology Co ltd filed Critical Huizhou Kailisi Technology Co ltd
Priority to CN202010794422.6A priority Critical patent/CN111909209A/en
Publication of CN111909209A publication Critical patent/CN111909209A/en
Priority to US17/172,021 priority patent/US11306112B2/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65744Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/1845Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing phosphorus
    • B01J31/185Phosphites ((RO)3P), their isomeric phosphonates (R(RO)2P=O) and RO-substitution derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C07C45/50Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide by oxo-reactions
    • C07C45/505Asymmetric hydroformylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • B01J2231/321Hydroformylation, metalformylation, carbonylation or hydroaminomethylation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/827Iridium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2531/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • C07C2531/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • C07C2531/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a novel biphenyl tetradentate phosphite ligand 2,2 ', 6, 6' -tetra [ (1,1 '-biphenyl-2, 2' -diyl) phosphonite]A preparation method of (E) -3,3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl and derivatives thereof. The novel biphenyl tetradentate phosphonite ligand has a structure shown as a general formula I, wherein a substituent R in the general formula I can be a cyclic phosphine structure. The novel biphenyl tetradentate phosphonite ligand has better conversion rate and normal-iso ratio in a mixed/etherified carbon tetra (butylene) hydroformylation reaction system.

Description

Preparation method of biphenyl tetradentate phosphonite ligand
Technical Field
The invention relates to a preparation method of a novel biphenyl tetradentate phosphonite ligand 2,2 ', 6,6 ' -tetra [ (1,1 ' -biphenyl-2, 2 ' -diyl) phosphonite ] -3,3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl and derivatives thereof.
Background
Hydroformylation has found a very large industrial application since 1938 in professor Otto Roelen (Chem abstract, 1994, 38-550). Since aldehydes can be very easily converted into corresponding alcohols, carboxylic acids, esters, imines, and the like, which have important uses in organic synthesis, aldehydes synthesized by hydroformylation are synthesized on a large scale in industrial production. Aldehydes produced by hydroformylation in industrial production per year now reach 1000 ten thousand tons (adv. synth. catal.2009,351, 537- & 540).
In hydroformylation reactions, while bidentate and tetradentate phosphine ligands have been widely reported and patented by foreign large chemical companies such as BASF, Dow, Shell and Eastman and some research groups, multidentate phosphine ligands have rarely been reported (Org. Lett.2013,15,1048-. Therefore, the development of a novel efficient tetradentate phosphine oxide ligand and a preparation method thereof in the hydroformylation reaction have important significance.
Phosphites are industrially used mainly for antioxidants, heat stabilizers, flame retardants and the like in polymer materials such as plastics, rubbers and the like. It is a phosphorous acid hydroxy derivative, which can be classified into phosphorous acid monoester ROP (OH) according to the number of hydroxy groups in the molecule2Phosphorous acid diester (RO)2POH and Triphosphite (RO)3And P. The hydroxyl or alkoxy group is substituted with a halogen atom to form a halophosphite. Among the halophosphites, chlorophosphite is the most important intermediate of trivalent organophosphorus compounds. The most common method for industrially preparing phosphite ester is direct esterification, which means that halogenated material of trivalent phosphorus is used as raw material to react with alcohol by controlling certain reaction conditions.
Propylene is used as a raw material, and butyraldehyde which is a hydroformylation reaction product of the propylene is subjected to a series of reactions such as aldol condensation, hydrogenation and the like to obtain a plasticizer dioctyl phthalate (DEHP) which is widely applied in industry. DEHP yields in china are higher than 300 ten thousand tons per year, while annual yields in the world are as high as 1000 ten thousand tons. However, the price of propylene raw materials is increasing year by year, and the plasticizer DEHP has small molecular weight, is cracking and volatile, has large toxicity to human bodies, and has been prohibited from production and recycling by REACH regulation listed in European Union in 2015. Current improvement the current improved process is by mixing/ethersThe hydroformylation of the butene is carried out to obtain valeraldehyde, and the high molecular weight novel plasticizer DPHP is produced through similar subsequent reactions. DPHP is not easily cracked and has low toxicity. At present, the technology is expected to gradually replace the traditional technology. Traditionally based on PPh3The technology can only realize the hydroformylation of 1-butene, the production cost of 1-butene is high, and the cheaper raw material is mixed butene or butene after ether. The domestic hydroformylation industrial device mainly uses PPh3And bidentate phosphonite ligands (Biphephos) used in Dow Chemical (Dow Chemical) are dominant. With foreign catalysts and processes, in addition to the high royalties and process package transfer costs that must be paid, the Biphephos ligand of dow chemistry is unstable in air for a long time, is easily hydrolyzed, acidolyzed and tends to block pipelines, and sporadically added ligands are required to ensure catalytic activity.
Compared with the bidentate phosphonite ligand Biphephos, the preparation of the biphenyl tetradentate phosphonite ligand and the derivative thereof developed by the invention has the characteristics of easy synthesis, amplified synthesis, high yield, good reaction activity, high yield of straight-chain aldehyde products, extremely stable water and oxygen, difficult decomposition and the like. Meanwhile, through preliminary industrial small-scale research and comparison of Biphephos and other bidentate phosphine ligands, the novel biphenyl tetradentate phosphonite ligand developed by the invention can realize higher conversion rate, higher normal-iso ratio and better activity and stability in the hydroformylation reaction of mixed/etherified C4, and has great potential and practical value.
Disclosure of Invention
The invention aims to develop a high-efficiency synthesis method of biphenyl tetradentate phosphonite ligands and derivatives thereof. It is especially easy to synthesize, high in yield and capable of being synthesized in large scale. The structures of the compound and its derivatives are shown below:
Figure RE-GDA0002681147900000031
in formula I, R can be a cyclic phosphine structure of phosphite ester, and is shown in the formula. The synthetic route of the biphenyl tetraphosphine ligand is as follows:
the synthetic route is as follows:
Figure RE-GDA0002681147900000041
drawings
FIG. 1 shows a nuclear magnetic resonance hydrogen spectrum of a compound 2,2 ', 6,6 ' -tetramethoxy-3, 3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl (1H NMR);
FIG. 2 shows the NMR spectrum of ligand L1: (1H NMR);
FIG. 3 shows the phosphine nuclear magnetic resonance spectrum of ligand L1: (31P NMR);
FIG. 4 is a high resolution mass spectrum (UPLC APCI-TOF-MS) of ligand L1:
FIG. 5 is a high resolution isotope resolution mass spectrum (UPLC APCI-TOF-MS) of ligand L1.
Detailed Description
The above route of the present invention is described in detail by the following examples, which should be noted that the present invention is only for further illustration and not limited to the present invention. Those skilled in the art can make insubstantial modifications and adaptations to the present invention.
Example 1
Preparation of 2,2 ', 6,6 ' -tetramethoxy-1, 1 ' -biphenyl:
Figure RE-GDA0002681147900000042
1(13.8g), THF (200mL), tetramethylethylenediamine (16 g) were added to a 1L three-necked flask in this order, and n-butyllithium (40mL, 2.5mol/L) and then iron chloride (16.1g) were added under argon cooling at-78 ℃. The solvent was spin dried under reduced pressure, 400mL of water was added, and the mixture was extracted three times with ethyl acetate (500 mL each). The obtained organic phase is dried by anhydrous sodium sulfate, then is decompressed and dried by spinning, and the residue is subjected to flash column chromatography to obtain 22g of target product with the yield of 80%.
Example 2
Preparation of 2,2 ', 6,6 ' -tetrahydroxy-1, 1 ' -biphenyl:
Figure RE-GDA0002681147900000051
in a 1L four-necked round-bottomed flask, 2(27g) and 500mL of methylene chloride were sequentially added, and after completion of the addition, boron tribromide (101g) was dropped into the flask at-30 ℃ to raise the temperature of the resulting reaction system to 30 ℃ for 4 hours. The resulting reaction mixture was concentrated, 400mL of water was added, and the mixture was extracted three times with ethyl acetate (600 mL each). The residue was subjected to column chromatography to obtain 20.5g of the target product at a yield of 91%.
Example 3
Preparation of 2,2 ', 6,6 ' -tetramethoxy-3, 3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl:
Figure RE-GDA0002681147900000052
a dry 1L Schlenk flask was charged with 3(22.0g), the flask was replaced with a nitrogen atmosphere, and 200mL of tetrahydrofuran, organic or inorganic acid (1.0g) was added at 25 ℃. The reaction was continued for 12 hours with continued introduction of 1.5 atmospheres of isobutene. After the reaction solution was quenched with water, 300mL of water was added and extracted three times with ethyl acetate (400 mL each). The obtained organic phase is dried by anhydrous sodium sulfate and then is dried by decompression and spin-drying to obtain a light yellow solid, and the column chromatography is carried out to obtain 40.0g of a target product with the yield of 90 percent.1H NMR(600MHz, (CD3)2SO):=7.53(s,4H),7.17(s,2H),1.37(s,36H)。
Example 4
Preparation of 1,1 '-biphenyl-2, 2' -dioxychlorophosphine:
Figure RE-GDA0002681147900000061
20g of 2, 2' -biphenol was added to an excess of PCl3In the middle, heating and refluxingAfter 6 hours, excess PCl was removed by distillation under reduced pressure318g of 7 are obtained as yellow oil in 71% yield.
Example 5
Preparation of 2,2 ', 6,6 ' -tetrakis [ (1,1 ' -biphenyl-2, 2 ' -diyl) phosphonite ] -3,3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl (scheme 1):
Figure RE-GDA0002681147900000062
4.2g of 2,2 ', 6,6 ' -tetrahydroxy-3, 3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl and 100mL of anhydrous tetrahydrofuran were sequentially added to a 2L Schlenk flask under nitrogen protection, and 15 mL of 2.5M n-butyllithium was added dropwise at-78 ℃. The reaction mixture was warmed to room temperature and refluxed for 1 hour. Then, the reaction solution was dropped into 100mL of an anhydrous tetrahydrofuran solution of 1, 1' -dioxyphosphorochloridite (13g) at-78 ℃ and reacted at room temperature for 24 hours after completion of the dropping, the reaction solution was concentrated under a nitrogen atmosphere, and the residue was subjected to column chromatography to obtain 6.0g of the objective product with a yield of 46%.1H NMR (400MHz,CDCl3):=7.74(s,2H),7.48–7.38(m,8H),7.19(td,J=7.6,7.2,2.2 Hz,8H),7.11(dd,J=6.5,1.7Hz,16H),1.30(s,36H)。31P NMR(243MHz,CDCl3): =140.62。APCI-TOF/MS:Calculated for C76H71O12P4[M+H]+:1299.3818;Found: 1299.3891。
It is to be noted here that other biphenyl-type tetradentate phosphine ligands of L2-L26 of formula I can be prepared by using only different aryl-substituted phosphonium chloride derivatives as described in example 5.

Claims (8)

1. A method for preparing novel biphenyl tetradentate phosphite ligand and derivatives thereof is characterized by comprising the following synthetic routes:
Figure RE-FDA0002653076870000011
wherein, the structure of the novel biphenyl tetradentate phosphite ligand represented by the general formula I is as follows:
Figure RE-FDA0002653076870000012
Figure RE-FDA0002653076870000021
2. the method for preparing a novel biphenyl tetradentate phosphite ligand and its derivatives as claimed in claim 1, wherein the skeletal synthesis is carried out by the following reaction.
Figure RE-FDA0002653076870000022
Preparation of 2,2 ', 6,6 ' -tetramethoxy-1, 1 ' -biphenyl.
3. The method for preparing a novel biphenyl tetradentate phosphite ligand and its derivatives as claimed in claim 1, wherein the skeletal synthesis is carried out by the following reaction.
Figure RE-FDA0002653076870000023
Preparation of 2,2 ', 6,6 ' -tetrahydroxy-1, 1 ' -biphenyl.
4. The method for preparing a novel biphenyl tetradentate phosphite ligand and its derivatives as claimed in claim 1, wherein the skeletal synthesis is carried out by the following reaction.
Figure RE-FDA0002653076870000031
Preparation of 2,2 ', 6,6 ' -tetramethoxy-3, 3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl
The acid used in the above reaction may be one or more of an organic acid such as: formic acid, acetic acid, oxalic acid, dichloroacetic acid, trifluoroacetic acid, propionic acid, malonic acid, pyruvic acid, butyric acid, valeric acid, caproic acid, adipic acid, benzoic acid, p-nitrobenzoic acid, terephthalic acid, benzenesulfonic acid, fluorosulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, and the like; inorganic acids such as: hydrobromic acid, hydrochloric acid, hydrofluoric acid, sulfurous acid, sulfuric acid, perchloric acid, phosphonic acid, pyrophosphoric acid, nitric acid, nitrous acid, chromic acid, fluoroantimonic acid, and the like.
5. The process for the preparation of the novel biphenyl tetradentate phosphonite ligands and their derivatives as claimed in claim 1, characterized in that the skeletal synthesis is carried out by the following reaction.
Route 1
Figure RE-FDA0002653076870000032
Route 2
Figure RE-FDA0002653076870000033
Preparation of 2,2 ', 6,6 ' -tetrakis [ (1,1 ' -biphenyl-2, 2 ' -diyl) phosphonite ] -3,3 ', 5,5 ' -tetra-tert-butyl-1, 1 ' -biphenyl (L1)
Meanwhile, the ether solvent used in the above reaction may be any one of tetrahydrofuran, diethyl ether, 2-methyltetrahydrofuran or dioxane.
6. A novel process for the stepwise substitution of bidentate phosphine ligands (e.g., Biphephos) using novel biphenyl tetradentate phosphonites as ligands in mixed/ethereal hydroformylation reactions. The process is characterized in that the novel biphenyl tetradentate phosphonite ligands used may be as described in claim 1 having the general formula I.
7. A novel process as claimed in claim 6, wherein novel biphenyltetradentate phosphonites are used as ligands in mixed/ethereal carbohydroformylation and for stepwise substitution of bidentate phosphine ligands (e.g.Biphephos). The method is characterized by being realized according to the following process steps and parameters.
(1) Under the protection of inert gas, adding a certain proportion of novel biphenyl tetradentate phosphonite ligand and rhodium catalyst in a reaction device in sequence, wherein the molar ratio of phosphine to rhodium is about 1-5: 1, and stirring and complexing for 30 minutes at room temperature under an organic solvent.
(2) Then, under the protection of inert gas, under the switching of a two-position four-way valve, adding a certain proportion of liquid mixed C-C or C-C or cis-2-butene or trans-2-butene into the reaction kettle by using a plunger pump with a metering function, controlling the concentration of the rhodium catalyst to be about 50-200 ppm, and uniformly stirring at room temperature for 5-10 minutes.
(3) After stirring uniformly, filling CO and H with a certain pressure into the reaction device2The pressure ratio of hydrogen to carbon monoxide is between 1:1 and 1:5, and the total pressure is between 0.5MPa and 1 MPa; and stirring and reacting for 1-4 hours at the temperature of 40-80 ℃.
8. The reaction process according to claim 7,
the carbon four after the carbon four and the ether are mixed is as follows: mixing C-IV (1-butene (25 wt%), cis-2-butene (40 wt%) and trans-2-butene (35 wt%), C-IV after ether (isobutane (52.1 wt%), 1-butene (16.6 wt%), cis-2-butene (15.3 wt%) and trans-2-butene (16.0 wt%)), wherein the contents of the cis-2-butene and the trans-2-butene are more than 98.0 wt%;
or the organic solvent is any one of toluene, dichloromethane, dichloroethane, hexane, ethyl acetate, dioxane, tetrahydrofuran or n-valeraldehyde.
CN202010794422.6A 2020-02-10 2020-08-10 Preparation method of biphenyl tetradentate phosphonite ligand Pending CN111909209A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202010794422.6A CN111909209A (en) 2020-08-10 2020-08-10 Preparation method of biphenyl tetradentate phosphonite ligand
US17/172,021 US11306112B2 (en) 2020-02-10 2021-02-09 Biphenyl tetradentate phosphite compound: preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010794422.6A CN111909209A (en) 2020-08-10 2020-08-10 Preparation method of biphenyl tetradentate phosphonite ligand

Publications (1)

Publication Number Publication Date
CN111909209A true CN111909209A (en) 2020-11-10

Family

ID=73283412

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010794422.6A Pending CN111909209A (en) 2020-02-10 2020-08-10 Preparation method of biphenyl tetradentate phosphonite ligand

Country Status (1)

Country Link
CN (1) CN111909209A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112441893A (en) * 2020-12-01 2021-03-05 惠州凯特立斯科技有限公司 Hydroformylation method and catalyst for preparing isononanal
CN113912516A (en) * 2021-10-15 2022-01-11 浙江新和成股份有限公司 Application of multidentate phosphite ligand in catalytic synthesis of adiponitrile

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312996A (en) * 1992-06-29 1994-05-17 Union Carbide Chemicals & Plastics Technology Corporation Hydroformylation process for producing 1,6-hexanedials
CN1884244A (en) * 2006-05-31 2006-12-27 天津大学 Process for preparing 4,6-di-tert-butyl resorcin with resin as catalyst
CN101200476A (en) * 2006-12-13 2008-06-18 奥克森诺奥勒芬化学股份有限公司 Bisphosphite ligands for hydroformylation catalyzed by transition metals
US20100069680A1 (en) * 2007-03-20 2010-03-18 Eisenschmid Thomas C Hydroformylation process with improved control over product isomers
US20190292209A1 (en) * 2016-10-07 2019-09-26 Council Of Scientific & Industrial Research Novel compounds and process for preparation of the same from cashew nut shell liquid (cnsl)

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312996A (en) * 1992-06-29 1994-05-17 Union Carbide Chemicals & Plastics Technology Corporation Hydroformylation process for producing 1,6-hexanedials
CN1884244A (en) * 2006-05-31 2006-12-27 天津大学 Process for preparing 4,6-di-tert-butyl resorcin with resin as catalyst
CN101200476A (en) * 2006-12-13 2008-06-18 奥克森诺奥勒芬化学股份有限公司 Bisphosphite ligands for hydroformylation catalyzed by transition metals
US20100069680A1 (en) * 2007-03-20 2010-03-18 Eisenschmid Thomas C Hydroformylation process with improved control over product isomers
US20190292209A1 (en) * 2016-10-07 2019-09-26 Council Of Scientific & Industrial Research Novel compounds and process for preparation of the same from cashew nut shell liquid (cnsl)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZONGPENG ZHANG等: "New tetraphosphite ligands for regioselective linear hydroformylation of terminal and internalolefins", 《RSC ADV.》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112441893A (en) * 2020-12-01 2021-03-05 惠州凯特立斯科技有限公司 Hydroformylation method and catalyst for preparing isononanal
CN113912516A (en) * 2021-10-15 2022-01-11 浙江新和成股份有限公司 Application of multidentate phosphite ligand in catalytic synthesis of adiponitrile
CN113912516B (en) * 2021-10-15 2023-06-27 浙江新和成股份有限公司 Application of multidentate phosphite ligand in catalytic synthesis of adiponitrile

Similar Documents

Publication Publication Date Title
CN112159313A (en) Preparation method of big steric-hindrance bi-phenol skeleton and phosphonite ligand thereof
US5210318A (en) Catalysts and processes useful in producing 1,3-diols and/or 3-hydroxyldehydes
US4851581A (en) Chelate ligands for low pressure hydroformylation catalyst and process employing same
JP5591231B2 (en) Process for producing a C5-aldehyde mixture having a high n-pentanal content
KR102602992B1 (en) Economical production of 2-propylheptanol
CN111909209A (en) Preparation method of biphenyl tetradentate phosphonite ligand
US4742178A (en) Low pressure hydroformylation of dienes
CN1292728A (en) Catalyst comprising complex of metal of subgroup VIII, on basis of phosphonite ligand and method for hydroformylation
CN1627990B (en) Method for hydroformylation using catalyst of xanthene-bridged ligands
CN111909207B (en) Preparation of novel biphenyl tetradentate phosphonite ligand and application of ligand in mixed/etherified carbon tetrahydroformylation reaction
KR20020080416A (en) Phosphor, Arsenic And Antimony Compounds Based Upon Diaryl-anellated Bicyclo[2.2.n] Parent Substances And Catalysts Containing Same
TWI239267B (en) Phosphonite ligands, catalyst compositions and hydroformylation process utilizing same
CN113583045A (en) Catalyst composition containing bidentate phosphine ligand and application thereof
CN112010906B (en) Bisphosphite and preparation method and application thereof
TWI399364B (en) Co-production method of normal butanol and isobutyl aldehyde
CN112341494A (en) Novel large steric hindrance biphenyl triphenol skeleton and synthetic method of tridentate phosphonite ligand thereof
WO2012116977A1 (en) PROCESS FOR THE PREPARATION OF 3-METHYLENE-γ-BUTYROLACTONE
CN107108426A (en) The manufacture method and acetal compound of aldehyde compound
WO2019006774A1 (en) Method for preparing didopo compound
US4824977A (en) Chelating ligands and catalysts and processes employing the same
CN114988991B (en) Method for preparing isomeric aldehyde by hydroformylation of olefin
US7160835B2 (en) Bisphosphine process for producing the same and use thereof
CN108047013B (en) Synthetic method of isopentenal
CN107628948B (en) Process for the alkoxycarbonylation of alcohols
KR101989243B1 (en) Phosphorous acid P,P'-[5,5',6,6'-tetramethyl-3,3'-bis(1-methylethyl)[1,1'-biphenyl]-2,2'-diyl] P,P,P',P'-tetrakis(2,4-dimethylphenyl) ester in hydroformylation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201110

RJ01 Rejection of invention patent application after publication